Market Size (2018)
2018
$50.22B
Vertical: HealthcareBase Year: 202112 Sections
Market Size (2018)
2018
$50.22B
Projected (2030)
2030
$120.80B
CAGR (2018–2030)
7.6%
7.6%Key Players
105+
The growth of the global portable diagnostic devices market is attributed to the growing technological advancements, increasing incidences of chronic diseases, and increasing funding and investment through a public and private organizations. However, the lack of knowledge to run portable diagnostic devices is a hindrance to the market growth.
The Portable Diagnostic Devices Market market is projected to grow at a CAGR of 7.6% from 2018 to 2030.
Historical performance and future projections (2020–2030, USD Billion)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansMarket Size (USD Mn)
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansPortable diagnostic devices are technologically advanced devices that enable the user to perform diagnosis at the home, clinic, or in any remote area. Medical electronic devices are used for a wide range of applications such as therapy, diagnosis, patient health monitoring, and so on. The two biggest advantages of portable medical electronic devices are that they provide real-time patient monitoring solutions and offer tailored treatment of medical conditions, especially for diabetes and cardiovascular diseases. Portable medical electronic devices monitor the level of blood pressure, and body temperature, measure blood glucose levels, improve hearing, and much more.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSubscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThis report applies a rigorous multi-stage research process combining primary interviews, secondary data sources, and bottom-up market modelling to ensure accuracy and completeness across all segments and geographies.
Base Year
2021
Historical Period
2018 – 2021
Forecast Period
2021 – 2030
Primary Interviews
150+
Historical data (2018–2021) and forecast period (2021–2030)
Our research process spans primary interviews with industry stakeholders combined with comprehensive secondary data analysis, validated through triangulation across multiple independent sources.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansThreat Of New Entrants
The threat of new entrants in the global portable diagnostic devices market is relatively low. The global portable diagnostic devices market is growing drastically, hence attracting many new entrants who are looking to make a profit. However, development of such devices requires significant investment in research and development and establishing distribution channels and customer bases. In addition, regulatory approval is required for medical devices, which adds a significant barrier to entry. Companies aim to increase their market share and capture the market share which is mostly untouched by major players. Hence, the threat of new entrants in the global portable diagnostic devices market is expected relatively low.
Bargaining Power of Suppliers
The bargaining power of suppliers in the global portable diagnostic devices market is low as there is a limited number of suppliers for components such as sensors, microchips, and batteries, but these components are generally available from multiple sources. Moreover, the development of new portable diagnostic devices may lead to new suppliers entering the market, which is slightly decreasing the bargaining power of suppliers due to low switching costs. Additionally, the supply of raw materials is disrupted to some level due to the logistics issues that the world is facing currently, which in turn increases the bargaining power of suppliers.
Threat Of Substitutes
The threat of substitutes in the portable diagnostic devices in R&D market is low. Portable diagnostic devices there are few effective alternative diagnostic tools available, such as laboratory tests or medical imaging, portable diagnostic devices offer convenience and ease of use that other tool may not provide. There are several players offering similar products at competitive prices, which increases the threat of substitutes between players.
Bargaining Power Of Buyers
The bargaining power of buyers is moderate in the global portable diagnostic devices Market. Customers of portable diagnostic devices include healthcare providers, hospitals, and individuals. As these devices are often used for diagnosing and monitoring medical conditions, buyers are likely to have high bargaining power and be price sensitive.
Intensity Of Rivalry
The degree of competition in the portable diagnostic devices market is high owing to there are several key players in the market, each with their own products and pipelines. Additionally, the market is constantly evolving as new devices are developed and approved, leading to intense competition for market share. Companies must continue to invest in research and development to stay competitive and meet the changing needs of patients and healthcare providers. Such things might increase the level of product differentiation and will support the sales of the manufacturers.
Market estimates by geography (2030)
InsightNorth America leads with $47.26B by 2030, while Asia Pacific is projected to grow fastest at a 8.7% CAGR.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription Plans| REGION | 2018 | 2021 | 2030 | CAGR | SHARE |
|---|---|---|---|---|---|
| North America | $20.17B | $28.32B | $47.26B | 7.4% | 39% |
| Europe | $14.23B | $20.71B | $35.82B | 8.0% | 30% |
| Asia Pacific | $10.37B | $15.68B | $28.09B | 8.7% | 23% |
| Rest of the World | $5.44B | $6.73B | $9.64B | 4.9% | 8% |
| Total | $50.22B | $71.44B | $120.80B | 7.6% | 100% |
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansTotal Market Size
$120.80B
| APPLICATION | REVENUE ($B) | GROWTH RATE | MARKET PENETRATION |
|---|---|---|---|
| Diagnostic Imaging | $68.50B | 7.6% | 77% |
| Monitoring Devices | $52.31B | 7.6% | 77% |
* Revenue projections based on 2025 estimates. Growth rates represent CAGR 2024–2030. Market penetration indicates current adoption rate within addressable market segments.
Subscribe to Wantstats
Unlock premium reports, insights, blogs, charts and more.
View Subscription PlansSee plans for professionals or small and medium businesses.

Analytical insights on Portable Diagnostic Devices Market covering market dynamics, competitive landscape, and strategic outlook.
The Portable Diagnostic Devices Market market is projected to reach $120.80B by 2030, growing at 7.6% CAGR. The Diagnostic Imaging segment holds the largest share.
The growing technological advancements and increasing incidences of chronic diseases are driving the growth of the global portable diagnostic devices market during the forecast period. However, the lack of knowledge to run portable diagnostic devices is restraining the market growth. Nonetheless, it is anticipated that increasing funding and investment through public and private organizations will create lucrative opportunity pockets for the players operating in the global market.
The growing technological advancements in portable diagnostics offer benefits such as affordability, patient safety, and rapid & quality diagnosis. The market players are bringing new technologies into portable devices, such as 3D ultrasound, advanced features and tools at fingertips, and wireless ultrasound, which are driving the market's growth. For instance:
February 2023: Mindray (China) launched the wireless handheld ultrasound system TE Air, which is specifically designed to meet the demand of global healthcare professionals. It is simple to use in a variety of medical settings and provides clear point-of-care ultrasound (POCUS) imaging.February 2023: Abdul Latif Jameel Health (Saudi Arabia), a part of Abdul Latif Jameel (Saudi Arabia), collaborated with iSono Health (US) and launched a portable breast imaging scanner, which is now available in 31 countries. The product's specialty includes being a portable 3D ultrasound breast imaging scanner that uses automated imaging and artificial intelligence (AI).February 2021: Koninklijke Philips N.V. (Netherlands) launched a portable monitoring kit with advanced software. It is a medical tablet that has expanded Philips' remote patient monitoring, featuring an end-to-end, easy-to-implement kit.
Hence, the introduction of 3D and artificial intelligence (AI)-based portable diagnostic products is boosting the growth of the market.
The increasing funding and investment through public and private organizations are creating lucrative growth opportunities for the market during the forecast period. For instance,
September 2022: Temasek (Singapore) invested USD 85 million in Molbio Diagnostics Pvt. Ltd. (India). The funding will be used to develop "Truenat" technology, which is a portable, battery-operated real-time PCR platform for infectious diseases such as tuberculosis (TB), COVID-19, hepatitis-C virus, human papillomavirus, influenza, and vector-borne diseases like dengue, chikungunya, and malaria.June 2022: At Imperial College London (UK), researchers collaborated with institutions in Burkina Faso, the Gambia, Ghana, Kenya, the Netherlands, Sudan, Uganda, the UK, and Zambia and were awarded USD 3.21 million by the National Institute for Health and Care Research for digital handheld diagnostic devices.
Hence, the above-mentioned funding raised to develop and research portable diagnostic devices, which will be incorporated with high technology, is a great opportunity for the market.
The portable diagnostic devices market has been hindered by a lack of knowledge among the population to run the devices. The portable devices are designed for a large population to provide easy and quick results. However, not everyone can interpret the data that devices produce after imaging and monitoring, which has been shown to be a significant gap in research. People with less knowledge will end up interpreting the information in the wrong way, which may put the patient's health at risk.
Moreover, in this highly competitive era of technology, market players are incorporating tech-based portable diagnostic devices, including 3D and AI. In order to use these technologies, people must have sound knowledge to reach a conclusion through data interpretation. Hence, being unable to interpret the right data at the same time market players are incorporating technology-based portable diagnostic devices is the major pain point for market growth
Impact On Supply Chain
The pandemic has impacted the business environment for several organizations worldwide. The supply chain in the global portable diagnostic devices Market is the key to fulfilling customer demands. In addition, due to the pandemic, several countries have imposed import and export limitations. This has also affected the healthcare industry as many countries are dependent on other countries for raw material supply and technology transfer. However, regulatory bodies took significant initiatives to ensure efficient supply chain management during the pandemic. The closure of manufacturing facilities and transportation networks has also affected the production and distribution of portable devices. To overcome such challenges, key players also expanded their manufacturing capabilities to meet demand. Moderately impacted the global portable diagnostic devices Market.
Impact On Production
The COVID-19 pandemic has significantly and negatively impacted the global portable diagnostic devices market. The introduction of portable diagnostic devices has had a significant impact on production across various industries. These devices allow for faster, more accurate, and more efficient diagnosis of problems in equipment, which can help to reduce downtime and increase productivity.
However, there have also been negative impacts of the COVID-19 pandemic on the production and use of portable diagnostic devices. The increased demand for these devices has led to shortages, particularly in low- and middle-income countries, where access to these devices may be limited. This has highlighted the need for greater investment in the development and distribution of affordable and accessible portable diagnostic devices.
Impact On Regions
The COVID-19 pandemic has had a significant impact on regions around the world, including the development and use of portable diagnostic devices. In low- and middle-income countries, the impact has been particularly severe, as the pandemic has highlighted existing inequalities in access to healthcare and medical technologies. Many of these regions have experienced shortages of portable diagnostic devices, which has hindered their ability to respond effectively to the pandemic. Additionally, the high cost of these devices can make them inaccessible to healthcare providers or individuals in these regions, further exacerbating existing inequities.
Impact On Supply Gap Analysis
The COVID-19 pandemic has significantly impacted the global portable diagnostic devices market. During the pandemic decrease in the supply chain for portable diagnostic devices. This is due to various factors, such as the redirection of healthcare resources towards the management of COVID-19 patients, the suspension of elective procedures, and the reluctance of patients to visit healthcare facilities for fear of contracting the virus. As a result, many patients have delayed or postponed their treatments, which has led to a decline in the demand for portable diagnostic devices. This had a negative impact on the market.
Impact On Pricing
The COVID-19 pandemic had Moderate impacted in the market. The supply chain disruptions caused by the pandemic have led to shortages of critical components and raw materials used in the production of portable diagnostic devices, resulting in delays in manufacturing and distribution. The COVID-19 pandemic has also put pressure on healthcare systems and providers, leading to budget constraints and reduced investments in new technology and equipment, including portable diagnostic devices. This may limit the adoption of new and more advanced devices in the future.
Profiles of 105 companies operating in the Portable Diagnostic Devices Market market, including revenue, employee count, and market positioning where available.
Showing 105 of 105 companies
Emay
Company Headquarters: California, US Founded: 2016 Workforce: ~10 Company Working: Emay is a small-scale medical device manufacturing company which develops various medical devices such as ECG monitoring, sleep monitoring and other portable medical devices. The company has strong business presence in US, and it also distributes its products through e-commerce platforms like Amazon. Its team consists of experienced hardware and software engineers as well as medical device specialists. The company's marketing team is in constant contact with end users and understands their needs.
Wellue
Company Headquarters: California, US Founded: 2013 Workforce: ~5,000 Company Working: Wellue is a growing healthcare company which is involved in manufacturing of blood oxygen monitor, ECG monitor, handheld ultrasound, and others. The company offers products under the category of ECG monitors with AI analysis, continuous oxygen meters, blood pressure monitors, portable veterinary ultrasound, and others. The company has a strong distribution network in the US.
SAMSUNGHEALTHCARE.COM
Company Headquarters: California, US Founded: 1994 Workforce: ~ 1,600 Company Working: SAMSUNGHEALTHCARE.COM (Samsung Healthcare) is a manufacturer and distributor of diagnostic ultrasound device. It offers diagnostic ultrasound systems, digital radiography, and portable CT. It is dedicated to making medical advancements for both patient treatment and diagnostic solutions. The company’s innovation in healthcare is led by Samsung electronics’ health & medical equipment business and Samsung Madison. The company operates in North America, Europe, Latin America, Southeast/Asia, Middle East and Africa, and CIS countries.
Omron Healthcare Inc
Company Headquarters: Kyoto, Japan Founded: 1974 Workforce: ~4,095 Company Working: Omron Healthcare Inc. is a medical device company that provides high quality healthcare devices and solutions for home use. OMRON Healthcare is committed to developing technology that is in sync with the daily life—technology that advances toward a healthier world. It offers blood pressure monitors, fitness products, pedometers, heart rate monitors, pain management equipment, and other accessories. It is offering blood monitoring products for more than 50 years. The company has its presence in more than 110 countries around the world.
Koninklijke Philips N.V.
Company Headquarters: Amsterdam, Netherlands Founded: 1891 Workforce: ~81,592 Company Working: Koninklijke Philips N.V. (Philips) has a strong sales and distribution network worldwide and operates in more than 100 countries. Philips offers products through the following categories such as medical devices, health systems, cardiology, health tech, oncology, respiratory, fertility, and pregnancy segments. It offers products in maternity care, childcare, & oral healthcare products; male grooming & beauty products; food preparation & home care products; and sleep & respiratory care. It delivers diagnostic X-rays, integrated clinical solutions, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), and sand molecular imaging solutions. Moreover, it also offers healthcare IT, clinical, and visualization & quantification informatics solutions for radiology, cardiology, and oncology; universal data management solutions, picture archiving and communication systems, and integrated electronic medical record systems; clinical & hospital IT platforms; and technology-enabled monitoring & intervention, actionable program, cloud-based, and population health management software solutions.
Merge Healthcare Inc
Company Headquarters: Illinois, US Founded: 1994 Workforce: ~51,000 Company Working: GE Healthcare is part of the General Electric Company. The company's products are sold worldwide, primarily to hospitals, medical facilities, pharmaceutical and biotechnology companies, and the life science research industry. The company provides healthcare technologies in medical imaging, digital solutions, patient monitoring, diagnostics, drug discovery, biopharmaceutical manufacturing technologies, and performance enhancement solutions. General Electric Company has a strong presence in the global market in more than 160 countries.
Powering the world's best teams.
From next-gen startups to established enterprises.
Trusted by forward-thinking businesses
for data-driven intelligence
Portable Diagnostic Devices Market